| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | - | 0 | 242 | 2.445 | 712 | 13.637 | 14.087 | 0 | 33.607 |
| Total Income - EUR | 0 | - | 0 | 242 | 2.445 | 712 | 13.637 | 14.087 | 0 | 33.607 |
| Total Expenses - EUR | 0 | - | 0 | 40 | 26 | 3.493 | 7.939 | 7.515 | 0 | 24.994 |
| Gross Profit/Loss - EUR | 0 | - | 0 | 202 | 2.419 | -2.781 | 5.698 | 6.572 | 0 | 8.614 |
| Net Profit/Loss - EUR | 0 | - | 0 | 195 | 2.346 | -2.803 | 5.297 | 6.213 | 0 | 7.442 |
| Employees | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Novello Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 996 |
| Current Assets | 0 | - | 44 | 289 | 758 | 111 | 3.297 | 9.200 | 0 | 16.016 |
| Inventories | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | - | 43 | 42 | 41 | 40 | 40 | 40 | 0 | 77 |
| Cash | 0 | - | 2 | 247 | 717 | 70 | 3.257 | 9.160 | 0 | 15.938 |
| Shareholders Funds | 0 | - | -1.931 | -1.701 | 678 | -2.138 | 3.207 | 9.429 | 0 | 15.400 |
| Social Capital | 0 | - | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | 0 | - | 1.975 | 1.989 | 80 | 2.248 | 90 | 90 | 0 | 1.989 |
| Income in Advance | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Novello Med S.r.l.